Early research (Phase 1)WithdrawnNCT02528877
What this trial is testing
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
Who this might be right for
Acute Myeloid Leukemia in RemissionPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic Stage+2 more
City of Hope Medical Center